Black Race, Male Sex Tied to Use of Pharmacological Restraint in Pediatric Emergency Visits

THURSDAY, Dec. 22, 2022 (HealthDay News) -- In mental and behavioral health (MBH) emergency department visits for children, higher rates of pharmacologic restraint are associated with male sex, Black race, timing of visits, and revisits, according to a study published online Dec. 19 in Pediatrics.
Ashley A. Foster, M.D., from the University of California in San Francisco, and colleagues used emergency department visit data identified from the Pediatric Health Information System (2010 to 2020) to identify 545,800 visits by children (aged 3 to 21 years) with a primary MBH diagnosis. The association between patient- and hospital-level factors and pharmacologic restraint use was examined.
The researchers found that 4.1 percent of visits involved pharmacologic restraint use. Restraint was associated with visits by children aged 18 to 21 years (odds ratio, 1.88), male sex (odds ratio, 1.25), Black race (odds ratio, 1.22), visits starting overnight (odds ratio, 1.68), visits starting on a weekend (odds ratio, 1.26), and repeat emergency department visits (odds ratio, 1.31). While every 100-visit increase in average annual MBH volume was associated with a 0.09 percent decrease in restraint use, there was no significant association between average annual emergency department volume and restraint use.
"In mental and behavioral health emergency visits for children, male sex, Black race, timing of visits, and revisits were associated with pharmacologic restraint," the authors write. "These findings have implications for equitably managing agitation in youth in the pediatric emergency department."
Related Posts
AHA News: It’s the Flavor of the Season, But Be Wary of Peppermint Platitudes
WEDNESDAY, Dec. 14, 2022 (American Heart Association News) -- Peppermint, like...
Un medicamento muestra potencial para la esclerodermia, una enfermedad autoinmune
LUNES, 10 de octubre de 2022 (HealthDay News) -- Los investigadores informan un...
CDC Backs Boosters for High-Risk Kids Aged 5-11, Shorter Time Between Shots
TUESDAY, Jan. 4, 2022 (HealthDay News) -- The U.S. Centers for Disease Control...
Health Highlights: Feb. 24, 2022
Why is cancer-linked benzene in so many personal care products? The chemical is...
